Compare Yei Finance (Clovis) (CLO) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Yei Finance (Clovis) vs Enzyme — how do they compare? Yei Finance (Clovis) trades at Rp3,783 (market cap Rp487,41M, Rp181,01M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Yei Finance (Clovis) is far larger — about 3.6× Enzyme's market cap, and Yei Finance (Clovis)'s supply is capped (129,1M / 1B CLO (13%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Yei Finance (Clovis) for 2 Days and Enzyme for 28 Days on average.
| CLO | MLN | |
|---|---|---|
Market Cap | Rp487,41M | Rp134,13M |
Volume (24h) | Rp181,01M | Rp104,56M |
Circulating Supply | 129,1M / 1B CLO (13%) | 3,3M MLN |
Typical Hold Time | 2 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Yei Finance (CLO) is trading at Rp3,789.23 with a market cap of Rp496.12 million, showing a bullish technical signal overall. The token's circulating supply is 129,100 out of 1 million CLO, with a low circulation rate of 13% and a short hold time of 2 days. Key indicators like moving averages are strongly bullish, while oscillators are mixed with RSI levels suggesting overbought conditions. No recent protocol updates or ecosystem news are available.
The outlook is cautiously optimistic due to strong technical momentum, but risks include high volatility from low liquidity and overbought RSI signals. Opportunities lie in potential breakout above resistance levels, but investors should monitor for regulatory developments and liquidity depth.
Enzyme (MLN) shows a market cap of Rp134,13M with a circulating supply of 3,3jt tokens. The asset's price data is currently unavailable, but the hold time of 28 days suggests moderate trader retention. Recent news on ETF inflows may indirectly affect crypto sentiment, though no direct protocol updates are noted. Trading volumes and network activity metrics require verification from live crypto data sources for a complete picture.
Outlook: Enzyme faces typical crypto volatility risks with limited recent fundamental developments. Opportunities may arise from broader market trends, but investors should monitor liquidity and regulatory shifts closely. Major risks include low market cap susceptibility to manipulation and absence of max supply clarity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Yei Finance (Clovis)
Yei Finance (Clovis) is a liquidity abstraction layer designed to reunify fragmented capital across networks. It integrates cross-chain DEX, money markets, and bridging to provide on-demand global liquidity for multiple assets and chains. Its architecture enables liquidity providers to earn diversified yields while offering users near-instant cross-network transfers.
Read more on CLO →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
